| 发明名称 |
Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 摘要 |
PCT No. PCT/US96/11368 Sec. 371 Date Oct. 2, 1997 Sec. 102(e) Date Oct. 2, 1997 PCT Filed Jul. 8, 1996 PCT Pub. No. WO97/03959 PCT Pub. Date Feb. 6, 1997Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.
|
| 申请公布号 |
US5969156(A) |
申请公布日期 |
1999.10.19 |
| 申请号 |
US19970945812 |
申请日期 |
1997.09.29 |
| 申请人 |
WARNER-LAMBERT COMPANY |
发明人 |
BRIGGS, CHRISTOPHER A.;JENNINGS, REX A.;WADE, ROBERT;HARASAWA, KIKUKO;ICHIKAWA, SHIGERU;MINOHARA, KAZUO;NAKAGAWA, SHINSUKE |
| 分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/335;A01N43/36 |
主分类号 |
C07D207/34 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
